These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 27956846)
1. Repository corticotropin injection in patients with refractory psoriatic arthritis: a case series. Brown AN Open Access Rheumatol; 2016; 8():97-102. PubMed ID: 27956846 [TBL] [Abstract][Full Text] [Related]
2. Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action. Gillis T; Crane M; Hinkle C; Wei N Open Access Rheumatol; 2017; 9():131-138. PubMed ID: 28790870 [TBL] [Abstract][Full Text] [Related]
3. Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection. Hayes K; Panaccio MP; Houston P; Niewoehner J; Fahim M; Wan GJ; Dhillon B Open Access Rheumatol; 2021; 13():315-323. PubMed ID: 34703332 [TBL] [Abstract][Full Text] [Related]
4. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis. Busch H; Wan GJ; Niewoehner J; Houston P; Su Y; Clinton C; Panaccio MP Drugs Context; 2022; 11():. PubMed ID: 35382109 [TBL] [Abstract][Full Text] [Related]
5. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review. Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646 [TBL] [Abstract][Full Text] [Related]
6. Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies. Fischer PA; Rapoport RJ Open Access Rheumatol; 2018; 10():13-19. PubMed ID: 29445306 [TBL] [Abstract][Full Text] [Related]
7. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus. Askanase AD; Furie RA Adv Ther; 2022 Jul; 39(7):3088-3103. PubMed ID: 35641860 [TBL] [Abstract][Full Text] [Related]
8. A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States. Nelson WW; Philbin MJ; Gallagher JR; Heap K; Carroll S; Wan GJ Rheumatol Ther; 2017 Dec; 4(2):465-474. PubMed ID: 29071588 [TBL] [Abstract][Full Text] [Related]
9. Repository Corticotropin Injection as an Alternative Treatment for Refractory Ocular Mucous Membrane Pemphigoid. Sharon Y; Anesi SD; Martinez CE; Huang AJW; Foster CS; Chu DS Cornea; 2022 Jan; 41(1):45-51. PubMed ID: 34050065 [TBL] [Abstract][Full Text] [Related]
10. Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis. Fleischmann R; Hayes K; Ahn SW; Wan GJ; Panaccio M; Karlsson D; Furst DE Rheumatol Ther; 2022 Apr; 9(2):649-661. PubMed ID: 35184268 [TBL] [Abstract][Full Text] [Related]
11. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Chopra I; Qin Y; Kranyak J; Gallagher JR; Heap K; Carroll S; Wan GJ Ther Adv Respir Dis; 2019; 13():1753466619888127. PubMed ID: 31722624 [TBL] [Abstract][Full Text] [Related]
12. Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept. Decker DA; Higgins P; Hayes K; Bollinger C; Becker P; Wright D BMC Musculoskelet Disord; 2020 Aug; 21(1):586. PubMed ID: 32867752 [TBL] [Abstract][Full Text] [Related]
13. Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies. Patel A; Seely G; Aggarwal R Case Rep Rheumatol; 2016; 2016():9068061. PubMed ID: 27642533 [TBL] [Abstract][Full Text] [Related]
14. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications. Philbin M; Niewoehner J; Wan GJ Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550 [TBL] [Abstract][Full Text] [Related]
15. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review. Mirsaeidi M; Baughman RP Pulm Ther; 2022 Mar; 8(1):43-55. PubMed ID: 35113366 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot study. Furie R; Mitrane M; Zhao E; Das M; Li D; Becker PM Lupus Sci Med; 2016; 3(1):e000180. PubMed ID: 27933199 [TBL] [Abstract][Full Text] [Related]
17. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis. Mirsaeidi M; Baughman RP; Sahoo D; Tarau E Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607 [TBL] [Abstract][Full Text] [Related]
19. Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis. Fleischmann R; Hayes K; Ahn SW; Wan GJ; Panaccio MP; Karlsson D; Furst DE Rheumatol Ther; 2022 Apr; 9(2):435-446. PubMed ID: 34919213 [TBL] [Abstract][Full Text] [Related]